Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov
Condition: Urothelial Cancer
Study Type: Interventional
Study Start Date: 04/26/2019
Study Completion Date: 05/2020
This is an international, multi-center, open-label, phase II study in patients with metastatic urothelial cancer after failure of platinum-based regimen or anti-PD-1 /PD-L1 based immunotherapy.
At least 140 patients are anticipated to be enrolled across approximately 70 sites from North America, Europe and Asia.